4//SEC Filing
Ward Robert 4
Accession 0001415889-20-000595
CIK 0001035354other
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 6:30 PM ET
Size
11.9 KB
Accession
0001415889-20-000595
Insider Transaction Report
Form 4
Ward Robert
DirectorChief Executive Officer
Transactions
- Exercise/Conversion
Common Stock
2020-02-29+76,806→ 267,552 total - Exercise/Conversion
Restricted Stock Units
2020-02-29−71,199→ 0 total→ Common Stock (71,199 underlying) - Tax Payment
Common Stock
2020-02-29$3.13/sh−23,285$72,882→ 244,267 total - Exercise/Conversion
Restricted Stock Units
2020-02-29−5,607→ 0 total→ Common Stock (5,607 underlying)
Footnotes (6)
- [F1]The restricted stock units issued to the reporting person on December 26, 2017 have partially vested in accordance with the reporting person's employment agreement and settled for shares of the Issuer's common stock.
- [F2]Of this amount, 252,552 shares are held by the Robert E. Ward 2017 Revocable Trust of which Mr. Ward is a trustee.
- [F3]Of this amount, 229,267 shares are held by the Robert E. Ward 2017 Revocable Trust of which Mr. Ward is a trustee.
- [F4]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F5]The restricted stock units were issued pursuant to the Issuer's 2013 Share Ownership and Option Plan.
- [F6]As a result of reporting person's separation from the Issuer, 25% of all unvested equity accelerated in accordance with the reporting person's employment agreement and the remaining unvested equity was forfeited.
Documents
Issuer
Eloxx Pharmaceuticals, Inc.
CIK 0001035354
Entity typeother
Related Parties
1- filerCIK 0001595111
Filing Metadata
- Form type
- 4
- Filed
- Mar 2, 7:00 PM ET
- Accepted
- Mar 3, 6:30 PM ET
- Size
- 11.9 KB